Anne Wojcicki’s $305 million offer to reclaim 23andMe casts new light on the lives and legacies of the groundbreaking Wojcicki sisters.

23andMe co-founder and former CEO Anne Wojcicki is set to buy back the company through a nonprofit public benefit corporation, TTAM Research Institute.

Anne Wojcicki, the co-founder and former CEO of 23andMe MEHCQ-0.51%decrease; red down pointing triangle, is poised to regain control of the DNA-testing company after a nonprofit she controls ...

Anne Wojcicki regains control of 23andMe, the company she co-founded and led as CEO, through her nonprofit TTAM with a $305 million bid at a bankruptcy auction.

Former CEO Anne Wojcicki has prevailed in the bankruptcy auction of 23andMe, its consumer and biopharma research businesses, and its trove of genetic data. | Her $305 million offer topped the ...

A nonprofit led by Anne Wojcicki, the co-founder and former chief executive of 23andMe, won a bid to acquire the genetic testing company following its bankruptcy filing in March.

Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron Pharmaceuticals' offer for the DNA-testing company in a bankruptcy auction.

Anne Wojcicki's nonprofit will acquire substantially all of 23andMe's assets for $305 million, the company announced Friday. 23andMe filed for Chapter 11 bankruptcy protection in March.

23andMe could be back in the hands of former CEO Anne Wojcicki after her nonprofit offered $305 million to buy the company.

23andMe, which became a household name for its genetic testing services, is set to emerge from bankruptcy as a nonprofit.